![David Giljohann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Giljohann
Chief Executive Officer at
EVOQ Therapeutics, Inc.
Profile
David A. Giljohann is Chief Executive Officer at EVOQ Therapeutics, Inc. since 2023.
Former roles include Founding Scientist at Aurasense LLC, Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013, and Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Education includes undergraduate and doctorate degrees from Northwestern University.
David Giljohann active positions
| Companies | Position | Start |
|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Chief Executive Officer | 2022-12-31 |
Former positions of David Giljohann
| Companies | Position | End |
|---|---|---|
| EXICURE, INC. | Chief Executive Officer | 2021-12-09 |
Aurasense LLC
 Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Chief Tech/Sci/R&D Officer | 2008-12-31 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Chief Executive Officer | - |
Training of David Giljohann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
- Stock Market
- Insiders
- David Giljohann
Choose MarketScreener 
